J9037 Belantamab mafodontin-blmf - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Belantamab mafodontin-blmf

Brand Name:

Blenrep

Strength:

0.5mg

HCPCS:

J9037

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Drug Antibody Conjugate

Minor Drug Class:

BCMA

Oral (Y/N):

No

FDA Approval Year:

2020

FDA Discontinuation Year:

CMS Effective Date:

April 1, 2021

CMS Discontinuation Date:

Status:

In Use